Platelet-rich plasma in the treatment of anal fistula: a systematic review and meta-analysis

DOI: https://doi.org/10.1007/s00384-023-04367-z
IF: 2.8
2023-03-12
International Journal of Colorectal Disease
Abstract:To analyse the safety and effectiveness of platelet-rich plasma (PRP) in anal fistula patients. Online databases including PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to December 5, 2022, for eligible studies about evaluating the efficacy of platelet-rich plasma (PRP) in treating anal fistula. Literature search, screening, data extraction, and quality assessment were carried out by two independent investigators. The overall cure rate, the complete cure rate, the recurrence rate, and the adverse event rate with their 95% confidence intervals (95% CI) were the primary calculation indexes. Subgroup analyses were conducted primarily according to whether PRP was combined with other treatments. Softwares of MedCalc 18.2 and Review Manager 5.3 were used for meta-analysis.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?